of investment impact thanks to direct and in-kind support from partners
treatments of child-friendly Coartem® Dispersible distributed to more than 50 countries since 2009, saving around 860 000 lives
of injectable artesunate for severe malaria delivered since 2010, saving the lives of over 1m additional vulnerable children compared with quinine treatment
A new WHO report assesses progress and lessons learned in malaria elimination.
Read the article to learn more about what can be done to combat resistance to ACTs
Read more about MMV's initiative to combat malaria in women who are of reproductive potential, pregnant or breastfeeding.